Shares of companies that make COVID-19 vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths. The Washington Post ...
Tony Danza still thinks about the night Frank Sinatra yelled at him — 30 years ago. “I was singing to him,” Danza recalled of Ol’ Blue Eyes’ 1995 televised 80th birthday tribute, talking to The Post ...
Tony Danza talked to The Post about his life, career and his latest NYC cabaret act, "Sinatra and Stories," through Oct. 2. Yahoo is using AI to generate takeaways from this article. This means the ...
Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying ...
Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines. Trump health officials ...
Moderna became a household name during the pandemic because of its leading-edge technology. Investors, as is often the case, extended a positive trend too far into the future. The company's story ...
The three pharma companies that make COVID-19 vaccines authorized in the US, Pfizer (NYSE:PFE), Moderna (NASDAQ:MRNA), and Novavax (NASDAQ:NVAX) responded Wednesday to President Donald Trump’s recent ...
We recently published 11 Best Cancer Stocks to Buy Right Now. Moderna, Inc. stands fifth among them. Moderna, Inc. (NASDAQ:MRNA) stands fifth among the best cancer stocks. It is best known for its ...
Biotech company Moderna said Thursday it plans to cut 10% of its global workforce and expects to have fewer than 5,000 employees by the end of the year. The move is part of the company's ongoing ...
Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, announced Thursday that it will lay off about 10% of its workforce. Moderna CEO ...
In a note to employees Thursday, Moderna Inc. said it was laying off about 10% of its global workforce as part of the biotechnology company’s plan to cut annual costs by $1.5 billion over the next ...
Moderna, based in Cambridge, will lay off 10% of its workforce and expects “to be fewer than 5,000 colleagues strong” by the end of the year as part of its effort to cut costs. In a statement on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback